JPS6490133A - Pharmaceutical preparation for oral administration - Google Patents
Pharmaceutical preparation for oral administrationInfo
- Publication number
- JPS6490133A JPS6490133A JP62245592A JP24559287A JPS6490133A JP S6490133 A JPS6490133 A JP S6490133A JP 62245592 A JP62245592 A JP 62245592A JP 24559287 A JP24559287 A JP 24559287A JP S6490133 A JPS6490133 A JP S6490133A
- Authority
- JP
- Japan
- Prior art keywords
- active component
- histidylhistidine
- cyclo
- bis
- oral administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
PURPOSE:To provide the titled preparation containing bis[cyclo(histidylhistidine)] copper salt complex as an active component, effective in removing active oxygen and preventing the formation of lipid peroxide in the living body, exhibiting prolonged effect by oral administration and useful as a remedy for hepatic diseases, etc., having low side effect. CONSTITUTION:The objective preparation contains a bis[cyclo(histidylhistidine)] copper salt complex as an active component. The above active component is formed in the form of tablet, granule, etc., together with a conventional drug preparation carrier. The content of the active component compound is usually about 1-70wt.%, preferably about 1-30wt.% in the whole composition. The amount of the active component compound in the administration unit is preferably about 0.1-100mg. It may be administered in the form of parenteral drug e.g. injection according to the symptom. An example of the above active component compound is bis[cyclo(histidylhistidine)] copper (II) (ClO4<->)2.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62245592A JPS6490133A (en) | 1987-09-29 | 1987-09-29 | Pharmaceutical preparation for oral administration |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62245592A JPS6490133A (en) | 1987-09-29 | 1987-09-29 | Pharmaceutical preparation for oral administration |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS6490133A true JPS6490133A (en) | 1989-04-06 |
Family
ID=17136021
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62245592A Pending JPS6490133A (en) | 1987-09-29 | 1987-09-29 | Pharmaceutical preparation for oral administration |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6490133A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2806911A1 (en) * | 2000-03-28 | 2001-10-05 | Univ Rene Descartes | USE OF SOD MIMETICS IN THE TREATMENT OF HEPATOCELLULAR INSUFFICIENCY |
-
1987
- 1987-09-29 JP JP62245592A patent/JPS6490133A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2806911A1 (en) * | 2000-03-28 | 2001-10-05 | Univ Rene Descartes | USE OF SOD MIMETICS IN THE TREATMENT OF HEPATOCELLULAR INSUFFICIENCY |
WO2001072327A3 (en) * | 2000-03-28 | 2002-03-28 | Univ Paris Descartes | Use of analogues of superoxide dismutase for treating hepatocellular insufficiencies |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0234733B1 (en) | Pharmaceutical compositions | |
US5569670A (en) | Combination medications containing alpha-lipoic acid and related | |
EP1283054A4 (en) | Drugs for complications of diabetes and neuropathy and utilization thereof | |
CA2208047A1 (en) | Increasing creatine and glycogen concentration in muscle | |
KR920000324A (en) | Essential Fatty Acid Treatment | |
CA2297834C (en) | Chromium/biotin treatment of type ii diabetes | |
HUT67661A (en) | New pyrazine derivatives, their preparation and pharmaceutical compositions containing them | |
CA2072366A1 (en) | Carboxylic acid-metal ion-acid complexes | |
KR970025615A (en) | Cancer metastasis inhibitor | |
JPS63270626A (en) | Antiulcer agent | |
AU1879597A (en) | Tetraether lipids and liposomes containing said lipids, and use of the same | |
CA2016470C (en) | Pharmaceutical preparation and method of treatment for liver dysfunction | |
WO1991018606A3 (en) | Orally active nonaddicting analgesics | |
JPS6490133A (en) | Pharmaceutical preparation for oral administration | |
KR920702225A (en) | Pharmaceutical composition | |
JPS5350316A (en) | Drug composition for oral administration | |
JPS5551019A (en) | Drug containing alllee or 133zz7*88dehydroo retine acid and manufacture thereof | |
CA1197782A (en) | Pharmaceutical and dietary composition | |
JPH04244022A (en) | Drug for suppressing thyroid-stimulating hormone and curing struma | |
JPS56115715A (en) | Physiologically active agent containing (3- dimethylcarbam-oxyphenyl) trimethyl ammonium derivative | |
KR900700102A (en) | Long-lasting composition of propaphenone and quinidine for the treatment of heart disease | |
KR910006270A (en) | Pharmacologically active compound preparations and uses | |
JPS646214A (en) | Remedy for ulcerative colonopathy | |
SU606242A1 (en) | "dimotziphon" anti-leprose preparation | |
JPS63192717A (en) | Drug for hepatic disease |